- SLXP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $140.5 million.
- SLXP traded 225,829 shares today in the pre-market hours as of 7:38 AM, representing 14.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SLXP with the Ticky from Trade-Ideas. See the FREE profile for SLXP NOW at Trade-Ideas More details on SLXP: Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. SLXP has a PE ratio of 163.3. Currently there are 12 analysts that rate Salix Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Salix Pharmaceuticals has been 1.9 million shares per day over the past 30 days. Salix has a market cap of $8.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.80 and a short float of 20.1% with 5.80 days to cover. Shares are up 55.1% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.